Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection

4 May 2022

Abstract excerpt

Background: Lung cancer (LC) is a leading cause of cancer-deaths globally. Its lethality is due in large part to the paucity of accurate screening markers. Precision Medicine includes the use of omics technology and novel analytic approaches for biomarker development. We combined Artificial Intelligence (AI) and DNA methylation analysis of circulating cell-free tumor DNA (ctDNA), to identify putative biomarkers...

Topics

Join the communities discussing this publication.

Cancer Genomics and Diagnostics
Epigenetics and DNA Methylation
Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35600397
DOI: 10.3389/fonc.2022.790645

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer DetectionPMID 35600397Read ↗

Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directionsSemantic proximity Read ↗

Genomics and the early diagnosis of lung cancerSemantic proximity Read ↗

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypesSemantic proximity Read ↗

A Novel Epigenetic Signature for Early Diagnosis in Lung CancerSemantic proximity Read ↗

Advances in methylation analysis of liquid biopsy in early cancer detection of colorectal and lung cancerSemantic proximity Read ↗

Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicineSemantic proximity Read ↗

The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS EraSemantic proximity Read ↗

Cost-effective shallow genome-wide sequencing for profiling plasma cfDNA signatures to enhance lung cancer detection.Semantic proximity Read ↗

Integrating genomic features for non-invasive early lung cancer detection.Semantic proximity Read ↗

Subtyping Lung Cancer Using DNA Methylation in Liquid BiopsiesSemantic proximity Read ↗

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNASemantic proximity Read ↗

Cell-free Tumor Methylome Analysis of Small Cell Lung Cancer Patients Identifies Subgroups with Prognostic AssociationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.